Raffo rebrands as Adium in Argentina

It’s been half a century since the founding of the Argentine drugmaker Raffo, and 2025 is a pivotal year as it starts a new era under a new name. As part of a regional rebrand that’s gradually rolling out across the company’s Latin American operations, the company that was founded in 1975 will now operate under the name Adium in Argentina. See LinkedIn

The rebranding began in 2023 in Brazil, where the company was previously known as Zodiac. After that, the Adium name was adopted in México and Colombia. Chile and Peru followed last month, and now it’s the turn of the company’s home country of Argentina. Paraguay and Central American operations have still to follow. See Article

The idea is to consolidate the names used in different markets under a single brand, which Adium plans to use as a launchpad for further international expansion. The company has informed the medical community that the rebrand in Argentina will take some time to fully implement given Raffo’s size and presence in the market.

A video (see below) announcing the name change recaps the drugmaker’s history, from its foundation by Julio Rodríguez Espósito to the launch of its plant in San Juan, which recently received a new injection of capital, and its current market position. Watch video // See Article

Last year, Jorge Belluzzo retired after over two decades as gerente general and 36 years in the company. At the helm now is Claudio Beramendi, who has been with the company for two decades. See Article

Adium is now present in close to 20 countries, including Ecuador, Uruguay and Venezuela, and has five production plants. It has clarified that Nolter, which was spun off in 2022, will continue to operate independently under its own name. See Spin Off‘s article

Raffo con mega fiesta en La Rural